| http://dbpedia.org/ontology/abstract
|
BioMotiv is an accelerator company associa … BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.nd partnering of the therapeutic products.
|
| http://dbpedia.org/ontology/foundingYear
|
2012
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/BioMotiv_Logo_REvised.jpg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.fastercures.org/assets/Uploads/VOD-TranslationalResearch2.pdf +
, http://www.biomotiv.com +
, https://www.wsj.com/articles/SB10001424052970203961204577267814201399918 +
, http://www.uhhospitals.org/services/harrington-discovery-institute +
|
| http://dbpedia.org/ontology/wikiPageID
|
42576177
|
| http://dbpedia.org/ontology/wikiPageLength
|
8466
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1066058182
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/SmithKline_Beecham +
, http://dbpedia.org/resource/McKinsey_&_Company +
, http://dbpedia.org/resource/Cleveland%2C_Ohio +
, http://dbpedia.org/resource/Inflammatory_bowel_disease +
, http://dbpedia.org/resource/Cardiology +
, http://dbpedia.org/resource/University_of_California%2C_San_Francisco +
, http://dbpedia.org/resource/Medical_Research +
, http://dbpedia.org/resource/Icahn_School_of_Medicine_at_Mount_Sinai +
, http://dbpedia.org/resource/University_of_Pennsylvania +
, http://dbpedia.org/resource/Oxford%2C_England +
, http://dbpedia.org/resource/Psoriasis +
, http://dbpedia.org/resource/Drug_development +
, http://dbpedia.org/resource/Category:Companies_based_in_Cleveland +
, http://dbpedia.org/resource/Charles_River_Laboratories +
, http://dbpedia.org/resource/Translational_Research +
, http://dbpedia.org/resource/Indiana_University +
, http://dbpedia.org/resource/Cleveland_Clinic +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Biogen +
, http://dbpedia.org/resource/University_of_Pittsburgh +
, http://dbpedia.org/resource/Cardinal_Health +
, http://dbpedia.org/resource/Johnson_&_Johnson +
, http://dbpedia.org/resource/University_of_Michigan +
, http://dbpedia.org/resource/Cancer +
, http://dbpedia.org/resource/Cardiovascular +
, http://dbpedia.org/resource/Immunology +
, http://dbpedia.org/resource/New_York_University +
, http://dbpedia.org/resource/University_of_Washington +
, http://dbpedia.org/resource/Ankylosing_spondylitis +
, http://dbpedia.org/resource/Category:Biotechnology +
, http://dbpedia.org/resource/Proof_of_concept +
, http://dbpedia.org/resource/University_of_Auckland +
, http://dbpedia.org/resource/Neurology +
, http://dbpedia.org/resource/The_Harrington_Project +
, http://dbpedia.org/resource/University_Hospitals_of_Cleveland +
, http://dbpedia.org/resource/Case_Western_Reserve_University +
, http://dbpedia.org/resource/Venture_capital +
, http://dbpedia.org/resource/Pharmaceutical_companies +
, http://dbpedia.org/resource/Takeda_Pharmaceutical_Company +
|
| http://dbpedia.org/property/foundation
|
Cleveland, Ohio, 2012
|
| http://dbpedia.org/property/industry
|
Biotechnology
|
| http://dbpedia.org/property/keyPeople
|
Baiju Shah, CEO
|
| http://dbpedia.org/property/logo
|
BioMotiv_Logo_REvised.jpg
|
| http://dbpedia.org/property/subsid
|
Koutif Therapeutics
, Inclera
, Allinaire Therapeutics
, Kodosil Bio
, SapVax
, Dual Therapeutics
, Nynex Therapeutics
, Sujana
, Optikira
, Orca Therapeutics
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Advert +
, http://dbpedia.org/resource/Template:Infobox_company +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology +
, http://dbpedia.org/resource/Category:Companies_based_in_Cleveland +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/BioMotiv?oldid=1066058182&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/BioMotiv_Logo_REvised.jpg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/BioMotiv +
|
| owl:sameAs |
http://yago-knowledge.org/resource/BioMotiv +
, https://global.dbpedia.org/id/fMRH +
, http://www.wikidata.org/entity/Q16987878 +
, http://dbpedia.org/resource/BioMotiv +
, http://rdf.freebase.com/ns/m.010f8lng +
|
| rdf:type |
http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInCleveland%2COhio +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
BioMotiv is an accelerator company associa … BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.nd partnering of the therapeutic products.
|
| rdfs:label |
BioMotiv
|
